🔎 Trials Near Me

Akèy › Maladi Entestinal Anflamatwa › Washington

Etid klinik pou Maladi Entestinal Anflamatwa nan Washington, DC

7 etid pou Maladi Entestinal Anflamatwa ap chèche patisipan nan sit nan ak bò kote Washington (nan yon distans apeprè 30 mil). Louvri yon etid pou wè ki moun ki ka patisipe ak kijan pou kontakte ekip etid la.

Tèks ofisyèl etid la (Anglè)

Ap chèche patisipan pou yon etid? Mete l anwo paj sa a — $99 pou 30 jou →

Immune Regulation in Ulcerative Colitis or Crohn s Disease

Ap rekriteEtid obsèvasyonVolontè an sante akeyi
  • National Institutes of Health Clinical Center, Bethesda · 7 mi lwen
1 Day – 75 Years · Tout sèks · Mizajou Oct 5, 2026 · NCT00001184

Longitudinal Immunophenotyping of Patients With Inflammatory Bowel Disease

Ap rekriteEtid obsèvasyon
  • National Institutes of Health Clinical Center, Bethesda · 7 mi lwen
Laj 18 a 85 · Tout sèks · Mizajou Oct 5, 2026 · NCT07619547

Testing an Immunotherapy Anti-cancer Drug, Nivolumab, for Advanced Cancers in Patients With Autoimmune Disorders, AIM-NIVO

Ap rekriteFaz 1
  • MedStar Georgetown University Hospital, Washington D.C.
  • National Cancer Institute Developmental Therapeutics Clinic, Bethesda · 7 mi lwen
Laj 18 ak plis · Tout sèks · Mizajou Oct 5, 2026 · NCT03816345

Unraveling the Mechanisms Underlying Primary Sclerosing Cholangitis Through a Multidisciplinary, Integrative Research Approach

Ap rekriteEtid obsèvasyonVolontè an sante akeyi
  • National Institutes of Health Clinical Center, Bethesda · 7 mi lwen
Laj 18 a 90 · Tout sèks · Mizajou Sep 22, 2026 · NCT04685200

Clinical and Basic Investigations Into Hermansky-Pudlak Syndrome

Ap rekriteEtid obsèvasyon
  • National Institutes of Health Clinical Center, Bethesda · 7 mi lwen
1 Month – 115 Years · Tout sèks · Mizajou Sep 9, 2026 · NCT00001456

Therapeutic Endpoint in Pediatric IBD Conditions

Ap rekriteEtid obsèvasyon
  • Children's National Health System, Washington D.C.
Laj 6 a 21 · Tout sèks · Mizajou Apr 8, 2026 · NCT06065228

Study of Efficacy and Adherence to Subcutaneous vs. Intravenous Vedolizumab in Patients With Inflammatory Bowel Disease Using a Novel Remote MONITORing Intervention

Ap rekriteEtid obsèvasyon
  • Capital Digestive Care, Chevy Chase · 8 mi lwen
Laj 18 ak plis · Tout sèks · Mizajou May 8, 2025 · NCT06750731

Etid Maladi Entestinal Anflamatwa nan lòt vil

Lòt etid nan Washington

Sous ClinicalTrials.gov, done yo ranmase Oct 6, 2026. Chak etid gen kritè li pou li menm; ekip etid la deside ki moun ki ka patisipe.